Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 1
1987 1
1991 1
1992 1
1994 1
1996 1
1997 5
1998 3
1999 1
2000 14
2001 4
2002 12
2003 6
2004 10
2005 11
2006 8
2007 15
2008 26
2009 15
2010 15
2011 7
2012 4
2013 4
2014 5
2015 3
2016 1
2017 4
2018 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

167 results
Results by year
Filters applied: . Clear all
Page 1
Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.
Rummel MJ, Al-Batran SE, Kim SZ, Welslau M, Hecker R, Kofahl-Krause D, Josten KM, Dürk H, Rost A, Neise M, von Grünhagen U, Chow KU, Hansmann ML, Hoelzer D, Mitrou PS. Rummel MJ, et al. Among authors: kim sz. J Clin Oncol. 2005 May 20;23(15):3383-9. doi: 10.1200/JCO.2005.08.100. J Clin Oncol. 2005. PMID: 15908650 Clinical Trial.
Pancreatic involvement in patients with inborn errors of metabolism.
Hwang WJ, Lim HH, Kim YM, Chang MY, Kil HR, Kim JY, Song WJ, Levy HL, Kim SZ. Hwang WJ, et al. Among authors: kim sz. Orphanet J Rare Dis. 2021 Jan 20;16(1):37. doi: 10.1186/s13023-021-01685-9. Orphanet J Rare Dis. 2021. PMID: 33472655 Free PMC article. Review.
Identification of HERC5 and its potential role in NSCLC progression.
Wrage M, Hagmann W, Kemming D, Uzunoglu FG, Riethdorf S, Effenberger K, Westphal M, Lamszus K, Kim SZ, Becker N, Izbicki JR, Sandoval J, Esteller M, Pantel K, Risch A, Wikman H. Wrage M, et al. Among authors: kim sz. Int J Cancer. 2015 May 15;136(10):2264-72. doi: 10.1002/ijc.29298. Epub 2014 Nov 9. Int J Cancer. 2015. PMID: 25353388 Free article.
167 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page